189 related articles for article (PubMed ID: 37759434)
1. Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer.
Armstrong L; Willoughby CE; McKenna DJ
Cells; 2023 Sep; 12(18):. PubMed ID: 37759434
[TBL] [Abstract][Full Text] [Related]
2. The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p.
Armstrong L; Willoughby CE; McKenna DJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673886
[TBL] [Abstract][Full Text] [Related]
3. MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF.
Stafford MYC; McKenna DJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768146
[TBL] [Abstract][Full Text] [Related]
4. MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET.
Park NR; Cha JH; Sung PS; Jang JW; Choi JY; Yoon SK; Bae SH
Heliyon; 2022 Oct; 8(10):e11135. PubMed ID: 36281372
[TBL] [Abstract][Full Text] [Related]
5. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
Wang JR; Liu B; Zhou L; Huang YX
Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
[TBL] [Abstract][Full Text] [Related]
7. MiR-22-3p suppresses NSCLC cell migration and EMT via targeting RAC1 expression.
Wang X; Wang X; Jiang T; Zhang Z; Xie N; Yang G
Funct Integr Genomics; 2023 Aug; 23(3):281. PubMed ID: 37620594
[TBL] [Abstract][Full Text] [Related]
8. miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.
Josson S; Gururajan M; Hu P; Shao C; Chu GY; Zhau HE; Liu C; Lao K; Lu CL; Lu YT; Lichterman J; Nandana S; Li Q; Rogatko A; Berel D; Posadas EM; Fazli L; Sareen D; Chung LW
Clin Cancer Res; 2014 Sep; 20(17):4636-46. PubMed ID: 24963047
[TBL] [Abstract][Full Text] [Related]
9. MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC.
Zou T; Gao Y; Qie M
Ann Transl Med; 2021 Jan; 9(2):125. PubMed ID: 33569427
[TBL] [Abstract][Full Text] [Related]
10. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
11. miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1.
Fang YY; Tan MR; Zhou J; Liang L; Liu XY; Zhao K; Bao EC
Onco Targets Ther; 2019; 12():9449-9458. PubMed ID: 31819476
[TBL] [Abstract][Full Text] [Related]
12. MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer.
Zhang X; Ren Z; Xu J; Chen Q; Ma J; Liu Z; Kou J; Zhao X; Lang R; He Q
J Oncol; 2022; 2022():5514715. PubMed ID: 35256884
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer.
Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W
J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174
[TBL] [Abstract][Full Text] [Related]
14. miR-1-3p suppresses the epithelial-mesenchymal transition property in renal cell cancer by downregulating Fibronectin 1.
Liu J; Huang Y; Cheng Q; Wang J; Zuo J; Liang Y; Yuan G
Cancer Manag Res; 2019; 11():5573-5587. PubMed ID: 31417307
[TBL] [Abstract][Full Text] [Related]
15. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
[TBL] [Abstract][Full Text] [Related]
16. MiR-1-3p Suppresses Colorectal Cancer Cell Proliferation and Metastasis by Inhibiting YWHAZ-Mediated Epithelial-Mesenchymal Transition.
Du G; Yu X; Chen Y; Cai W
Front Oncol; 2021; 11():634596. PubMed ID: 33718221
[TBL] [Abstract][Full Text] [Related]
17. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200c-3p/ZEB2 loop plays a crucial role in the tumor progression of prostate carcinoma.
Zhang J; Zhang H; Qin Y; Chen C; Yang J; Song N; Gu M
Ann Transl Med; 2019 Apr; 7(7):141. PubMed ID: 31157262
[TBL] [Abstract][Full Text] [Related]
19. MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition.
Ding X; Zhang J; Feng Z; Tang Q; Zhou X
Dig Dis Sci; 2021 Jul; 66(7):2272-2282. PubMed ID: 32749639
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
